VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q89426610  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000349.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q89426610‏
024 ‎‡a  0000-0002-8101-6009‏ ‎‡2  orcid‏
024 ‎‡a  7202526550‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q89426610‏
100 0 ‎‡a  Edwin K. Jackson‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  Edwin K Jackson‏ ‎‡c  onderzoeker‏ ‎‡9  nl‏
670 ‎‡a  Author's 2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism‏
670 ‎‡a  Author's 2-Methoxyestradiol Attenuates Angiotensin II-Induced Hypertension, Cardiovascular Remodeling, and Renal Injury‏
670 ‎‡a  Author's 8-Aminoguanine Induces Diuresis, Natriuresis, and Glucosuria by Inhibiting Purine Nucleoside Phosphorylase and Reduces Potassium Excretion by Inhibiting Rac1.‏
670 ‎‡a  Author's 8-Aminoguanosine and 8-Aminoguanine Exert Diuretic, Natriuretic, Glucosuric, and Antihypertensive Activity‏
670 ‎‡a  Author's A comparison of nucleoside transport and metabolism in hypertensive and normotensive rats‏
670 ‎‡a  Author's A possible antihypertensive mechanism of propranolol: antagonism of angiotensin II enhancement of sympathetic nerve transmission through prostaglandins‏
670 ‎‡a  Author's Adenosine Attenuates Human Coronary Artery Smooth Muscle Cell Proliferation by Inhibiting Multiple Signaling Pathways That Converge on Cyclin D.‏
670 ‎‡a  Author's Adenosine Biosynthesis in the Collecting Duct‏
670 ‎‡a  Author's Adenosine production by brain cells‏
670 ‎‡a  Author's Aging increases the expression of vasopressin receptors in both the kidney and urinary bladder‏
670 ‎‡a  Author's Alkaline Phosphatase Inhibitors Attenuate Renovascular Responses to Norepinephrine.‏
670 ‎‡a  Author's Angiotensin II-Induced [3H]Adenosine Release from in situ Rat Lung‏
670 ‎‡a  Author's Angiotensin II type 2 receptor regulates ROMK-like K⁺ channel activity in the renal cortical collecting duct during high dietary K⁺ adaptation‏
670 ‎‡a  Author's Application of the fast‐evaporation sample preparation method for improving quantification of angiotensin II by matrix‐assisted laser desorption/ionization‏
670 ‎‡a  Author's Attenuation of cisplatinum-induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide‏
670 ‎‡a  Author's Attenuation of noradrenergic neurotransmission by the thromboxane synthetase inhibitor, UK 38,485‏
670 ‎‡a  Author's Blockade of ENaCs by amiloride induces c-Fos activation of the area postrema‏
670 ‎‡a  Author's Cardiovascular and Renal Effects of Blocking A1 Adenosine Receptors‏
670 ‎‡a  Author's Characterization of the N6-etheno-bridge method to assess extracellular metabolism of adenine nucleotides: detection of a possible role for purine nucleoside phosphorylase in adenosine metabolism‏
670 ‎‡a  Author's Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia‏
670 ‎‡a  Author's Comments on Postma et al's "The effect of caffeine on renal vein renin concentration in patients with renal arterial disease"‏
670 ‎‡a  Author's Decreased Expression of Kv4.2 and Novel Kv4.3 K + Channel Subunit mRNAs in Ventricles of Renovascular Hypertensive Rats‏
670 ‎‡a  Author's Decreased expression of Kv4.2 and novel Kv4.3 K+ channel subunit mRNAs in ventricles of renovascular hypertensive rats‏
670 ‎‡a  Author's Dipeptidyl Peptidase IV Inhibition Alters the Hemodynamic Response to Angiotensin-Converting Enzyme Inhibition in Humans With the Metabolic Syndrome‏
670 ‎‡a  Author's Dual A1/A2B Receptor Blockade Improves Cardiac and Renal Outcomes in a Rat Model of Heart Failure with Preserved Ejection Fraction‏
670 ‎‡a  Author's Editorial for "Hypertension's 3 Dilemmas & 3 Solutions: Pharmacology of the Kidney in Hypertension".‏
670 ‎‡a  Author's Effect of Angiotensin II on Plasma Adenosine Concentrations in the Rat‏
670 ‎‡a  Author's Effects of angiotensin subtype 1 and subtype 2 receptor antagonists in normotensive versus hypertensive rats‏
670 ‎‡a  Author's Effects of chronic treatment with caffeine on kidney responses to angiotensin II‏
670 ‎‡a  Author's Effects of short-term beta blockade on blood pressure, plasma thromboxane B2, and plasma and urinary prostaglandins E2 and F2 alpha in normal subjects‏
670 ‎‡a  Author's Effects of short-term beta blockade on blood pressure, plasma thromboxane B2, and plasma and urinary prostaglandins E2 and F2α in normal subjects‏
670 ‎‡a  Author's Estrogens in Men: Another Layer of Complexity of Estradiol Metabolism in Pulmonary Hypertension‏
670 ‎‡a  Author's Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence‏
670 ‎‡a  Author's Experimental intravascular hemolysis induces hemodynamic and pathological pulmonary hypertension: association with accelerated purine metabolism.‏
670 ‎‡a  Author's Extracellular Ubiquitin‏
670 ‎‡a  Author's Extracellular Ubiquitin(1-76) and Ubiquitin(1-74) Regulate Cardiac Fibroblast Proliferation‏
670 ‎‡a  Author's Gene Therapy for Hypertension‏
670 ‎‡a  Author's Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells‏
670 ‎‡a  Author's Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer‏
670 ‎‡a  Author's Immunological mechanisms of the antitumor effects of supplemental oxygenation‏
670 ‎‡a  Author's Inhibition of angiotensin II potentiation of sympathetic nerve activity by beta-adrenergic antagonists‏
670 ‎‡a  Author's Interactive roles of CD73 and tissue nonspecific alkaline phosphatase in the renal vascular metabolism of 5'-AMP.‏
670 ‎‡a  Author's Mechanism of 17β-estradiol stimulated integration of human mesenchymal stem cells in heart tissue‏
670 ‎‡a  Author's Modulation of adrenergic transmission by angiotensins in the perfused rat mesentery‏
670 ‎‡a  Author's Modulation of Cyclic AMP Levels in Fallopian Tube Cells by Natural and Environmental Estrogens‏
670 ‎‡a  Author's Oviduct cells express the cyclic AMP-adenosine pathway‏
670 ‎‡a  Author's Oviduct Cells Express the Cyclic AMP-Adenosine Pathway1‏
670 ‎‡a  Author's Participation of prostaglandins in the control of renin release‏
670 ‎‡a  Author's Proteomic Analysis of Estrogen-Mediated Enhancement of Mesenchymal Stem Cell-Induced Angiogenesis In Vivo‏
670 ‎‡a  Author's Purine Metabolites in Tumor-Derived Exosomes May Facilitate Immune Escape of Head and Neck Squamous Cell Carcinoma‏
670 ‎‡a  Author's RACK1 regulates angiotensin II-induced contractions of SHR preglomerular vascular smooth muscle cells.‏
670 ‎‡a  Author's Receptor desensitization and blockade of the suppressive effects of prostaglandin E2 and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes‏
670 ‎‡a  Author's Regulation of 3′,5′-cAMP in Preglomerular Smooth Muscle and Endothelial Cells From Genetically Hypertensive Rats‏
670 ‎‡a  Author's Renal Extraction of Angiotensin II‏
670 ‎‡a  Author's Role of renal prostaglandins in sympathetically mediated renin relase in the rat.‏
670 ‎‡a  Author's Role of Renal Prostaglandins in Sympathetically Mediated Renin Release in the Rat‏
670 ‎‡a  Author's Saralasin-induced renin release: its blockade by prostaglandin synthesis inhibitors in the conscious rat‏
670 ‎‡a  Author's Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer‏
670 ‎‡a  Author's Synergistic Therapeutic Effects of 2-Methoxyestradiol With Either Sildenafil or Bosentan on Amelioration of Monocrotaline-induced Pulmonary Hypertension and Vascular Remodeling‏
670 ‎‡a  Author's The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury‏
670 ‎‡a  Author's The in situ blood perfused rat mesentery; A model for assessing modulation of adrenergic neurotranmission‏
670 ‎‡a  Author's The in situ blood perfused rat mesentery; a model for assessing modulation of adrenergic neurotransmission‏
670 ‎‡a  Author's The influence of chemotherapy on adenosine-producing B cells in patients with head and neck squamous cell carcinoma‏
670 ‎‡a  Author's α 2-Adrenoceptors: Challenges and Opportunities-Enlightenment from the Kidney‏
909 ‎‡a  (orcid) 0000000281016009‏ ‎‡9  1‏
909 ‎‡a  (scopus) 7202526550‏ ‎‡9  1‏
919 ‎‡a  immunologicalmechanismsoftheantitumoreffectsofsupplementaloxygenation‏ ‎‡A  Immunological mechanisms of the antitumor effects of supplemental oxygenation‏ ‎‡9  1‏
919 ‎‡a  2methoxyestradiolanendogenous17βestradiolmetaboliteinhibitsmicroglialproliferationandactivationviaanestrogenreceptorindependentmechanism‏ ‎‡A  2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism‏ ‎‡9  1‏
919 ‎‡a  2methoxyestradiolattenuatesangiotensin2inducedhypertensioncardiovascularremodelingandrenalinjury‏ ‎‡A  2-Methoxyestradiol Attenuates Angiotensin II-Induced Hypertension, Cardiovascular Remodeling, and Renal Injury‏ ‎‡9  1‏
919 ‎‡a  8aminoguanineinducesdiuresisnatriuresisandglucosuriabyinhibitingpurinenucleosidephosphorylaseandreducespotassiumexcretionbyinhibitingrac1‏ ‎‡A  8-Aminoguanine Induces Diuresis, Natriuresis, and Glucosuria by Inhibiting Purine Nucleoside Phosphorylase and Reduces Potassium Excretion by Inhibiting Rac1.‏ ‎‡9  1‏
919 ‎‡a  8aminoguanosineand8aminoguanineexertdiureticnatriureticglucosuricandantihypertensiveactivity‏ ‎‡A  8-Aminoguanosine and 8-Aminoguanine Exert Diuretic, Natriuretic, Glucosuric, and Antihypertensive Activity‏ ‎‡9  1‏
919 ‎‡a  comparisonofnucleosidetransportandmetabolisminhypertensiveandnormotensiverats‏ ‎‡A  A comparison of nucleoside transport and metabolism in hypertensive and normotensive rats‏ ‎‡9  1‏
919 ‎‡a  possibleantihypertensivemechanismofpropranololantagonismofangiotensin2enhancementofsympatheticnervetransmissionthroughprostaglandins‏ ‎‡A  A possible antihypertensive mechanism of propranolol: antagonism of angiotensin II enhancement of sympathetic nerve transmission through prostaglandins‏ ‎‡9  1‏
919 ‎‡a  adenosineattenuateshumancoronaryarterysmoothmusclecellproliferationbyinhibitingmultiplesignalingpathwaysthatconvergeoncyclin500‏ ‎‡A  Adenosine Attenuates Human Coronary Artery Smooth Muscle Cell Proliferation by Inhibiting Multiple Signaling Pathways That Converge on Cyclin D.‏ ‎‡9  1‏
919 ‎‡a  adenosinebiosynthesisinthecollectingduct‏ ‎‡A  Adenosine Biosynthesis in the Collecting Duct‏ ‎‡9  1‏
919 ‎‡a  adenosineproductionbybraincells‏ ‎‡A  Adenosine production by brain cells‏ ‎‡9  1‏
919 ‎‡a  agingincreasestheexpressionofvasopressinreceptorsinboththekidneyandurinarybladder‏ ‎‡A  Aging increases the expression of vasopressin receptors in both the kidney and urinary bladder‏ ‎‡9  1‏
919 ‎‡a  alkalinephosphataseinhibitorsattenuaterenovascularresponsestonorepinephrine‏ ‎‡A  Alkaline Phosphatase Inhibitors Attenuate Renovascular Responses to Norepinephrine.‏ ‎‡9  1‏
919 ‎‡a  angiotensin2inducedadenosinereleasefrominsituratlung‏ ‎‡A  Angiotensin II-Induced [3H]Adenosine Release from in situ Rat Lung‏ ‎‡9  1‏
919 ‎‡a  angiotensin2type2receptorregulatesromklikek+channelactivityintherenalcorticalcollectingductduringhighdietaryk+adaptation‏ ‎‡A  Angiotensin II type 2 receptor regulates ROMK-like K⁺ channel activity in the renal cortical collecting duct during high dietary K⁺ adaptation‏ ‎‡9  1‏
919 ‎‡a  applicationofthefastevaporationsamplepreparationmethodforimprovingquantificationofangiotensin2bymatrixassistedlaserdesorptionionization‏ ‎‡A  Application of the fast‐evaporation sample preparation method for improving quantification of angiotensin II by matrix‐assisted laser desorption/ionization‏ ‎‡9  1‏
919 ‎‡a  attenuationofcisplatinuminducednephrotoxicityintheratbyhighsaltdietfurosemideandacetazolamide‏ ‎‡A  Attenuation of cisplatinum-induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide‏ ‎‡9  1‏
919 ‎‡a  attenuationofnoradrenergicneurotransmissionbythethromboxanesynthetaseinhibitoruk38485‏ ‎‡A  Attenuation of noradrenergic neurotransmission by the thromboxane synthetase inhibitor, UK 38,485‏ ‎‡9  1‏
919 ‎‡a  blockadeofenacsbyamilorideinduces100fosactivationoftheareapostrema‏ ‎‡A  Blockade of ENaCs by amiloride induces c-Fos activation of the area postrema‏ ‎‡9  1‏
919 ‎‡a  cardiovascularandrenaleffectsofblockinga1adenosinereceptors‏ ‎‡A  Cardiovascular and Renal Effects of Blocking A1 Adenosine Receptors‏ ‎‡9  1‏
919 ‎‡a  characterizationofthen6ethenobridgemethodtoassessextracellularmetabolismofadeninenucleotidesdetectionofapossibleroleforpurinenucleosidephosphorylaseinadenosinemetabolism‏ ‎‡A  Characterization of the N6-etheno-bridge method to assess extracellular metabolism of adenine nucleotides: detection of a possible role for purine nucleoside phosphorylase in adenosine metabolism‏ ‎‡9  1‏
919 ‎‡a  circulatingexosomescarryinganimmunosuppressivecargointerferewithcellularimmunotherapyinacutemyeloidleukemia‏ ‎‡A  Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia‏ ‎‡9  1‏
919 ‎‡a  commentsonpostmaetalstheeffectofcaffeineonrenalveinreninconcentrationinpatientswithrenalarterialdisease‏ ‎‡A  Comments on Postma et al's "The effect of caffeine on renal vein renin concentration in patients with renal arterial disease"‏ ‎‡9  1‏
919 ‎‡a  decreasedexpressionofkv42andnovelkv43k+channelsubunitmrnasinventriclesofrenovascularhypertensiverats‏ ‎‡A  Decreased expression of Kv4.2 and novel Kv4.3 K+ channel subunit mRNAs in ventricles of renovascular hypertensive rats‏ ‎‡9  2‏
919 ‎‡a  dipeptidylpeptidase4inhibitionaltersthehemodynamicresponsetoangiotensinconvertingenzymeinhibitioninhumanswiththemetabolicsyndrome‏ ‎‡A  Dipeptidyl Peptidase IV Inhibition Alters the Hemodynamic Response to Angiotensin-Converting Enzyme Inhibition in Humans With the Metabolic Syndrome‏ ‎‡9  1‏
919 ‎‡a  duala1a2breceptorblockadeimprovescardiacandrenaloutcomesinaratmodelofheartfailurewithpreservedejectionfraction‏ ‎‡A  Dual A1/A2B Receptor Blockade Improves Cardiac and Renal Outcomes in a Rat Model of Heart Failure with Preserved Ejection Fraction‏ ‎‡9  1‏
919 ‎‡a  editorialforhypertensions3dilemmasand3solutionspharmacologyofthekidneyinhypertension‏ ‎‡A  Editorial for "Hypertension's 3 Dilemmas & 3 Solutions: Pharmacology of the Kidney in Hypertension".‏ ‎‡9  1‏
919 ‎‡a  effectofangiotensin2onplasmaadenosineconcentrationsintherat‏ ‎‡A  Effect of Angiotensin II on Plasma Adenosine Concentrations in the Rat‏ ‎‡9  1‏
919 ‎‡a  effectsofangiotensinsubtype1andsubtype2receptorantagonistsinnormotensiveversushypertensiverats‏ ‎‡A  Effects of angiotensin subtype 1 and subtype 2 receptor antagonists in normotensive versus hypertensive rats‏ ‎‡9  1‏
919 ‎‡a  effectsofchronictreatmentwithcaffeineonkidneyresponsestoangiotensin2‏ ‎‡A  Effects of chronic treatment with caffeine on kidney responses to angiotensin II‏ ‎‡9  1‏
919 ‎‡a  effectsofshorttermbetablockadeonbloodpressureplasmathromboxaneb2andplasmaandurinaryprostaglandinse2andf2αinnormalsubjects‏ ‎‡A  Effects of short-term beta blockade on blood pressure, plasma thromboxane B2, and plasma and urinary prostaglandins E2 and F2α in normal subjects‏ ‎‡9  1‏
919 ‎‡a  estrogensinmenanotherlayerofcomplexityofestradiolmetabolisminpulmonaryhypertension‏ ‎‡A  Estrogens in Men: Another Layer of Complexity of Estradiol Metabolism in Pulmonary Hypertension‏ ‎‡9  1‏
919 ‎‡a  exosomesinhnsccplasmaassurrogatemarkersoftumourprogressionandimmunecompetence‏ ‎‡A  Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence‏ ‎‡9  1‏
919 ‎‡a  experimentalintravascularhemolysisinduceshemodynamicandpathologicalpulmonaryhypertensionassociationwithacceleratedpurinemetabolism‏ ‎‡A  Experimental intravascular hemolysis induces hemodynamic and pathological pulmonary hypertension: association with accelerated purine metabolism.‏ ‎‡9  1‏
919 ‎‡a  extracellularubiquitin‏ ‎‡A  Extracellular Ubiquitin‏ ‎‡9  1‏
919 ‎‡a  extracellularubiquitin176andubiquitin174regulatecardiacfibroblastproliferation‏ ‎‡A  Extracellular Ubiquitin(1-76) and Ubiquitin(1-74) Regulate Cardiac Fibroblast Proliferation‏ ‎‡9  1‏
919 ‎‡a  genetherapyforhypertension‏ ‎‡A  Gene Therapy for Hypertension‏ ‎‡9  1‏
919 ‎‡a  generationandaccumulationofimmunosuppressiveadenosinebyhumancd4+cd25highfoxp3+regulatorytcells‏ ‎‡A  Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells‏ ‎‡9  1‏
919 ‎‡a  immunesuppressiveeffectsofplasmaderivedexosomepopulationsinheadandneckcancer‏ ‎‡A  Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer‏ ‎‡9  1‏
919 ‎‡a  inhibitionofangiotensin2potentiationofsympatheticnerveactivitybybetaadrenergicantagonists‏ ‎‡A  Inhibition of angiotensin II potentiation of sympathetic nerve activity by beta-adrenergic antagonists‏ ‎‡9  1‏
919 ‎‡a  interactiverolesofcd73andtissuenonspecificalkalinephosphataseintherenalvascularmetabolismof5amp‏ ‎‡A  Interactive roles of CD73 and tissue nonspecific alkaline phosphatase in the renal vascular metabolism of 5'-AMP.‏ ‎‡9  1‏
919 ‎‡a  mechanismof17βestradiolstimulatedintegrationofhumanmesenchymalstemcellsinhearttissue‏ ‎‡A  Mechanism of 17β-estradiol stimulated integration of human mesenchymal stem cells in heart tissue‏ ‎‡9  1‏
919 ‎‡a  modulationofadrenergictransmissionbyangiotensinsintheperfusedratmesentery‏ ‎‡A  Modulation of adrenergic transmission by angiotensins in the perfused rat mesentery‏ ‎‡9  1‏
919 ‎‡a  modulationofcyclicamplevelsinfallopiantubecellsbynaturalandenvironmentalestrogens‏ ‎‡A  Modulation of Cyclic AMP Levels in Fallopian Tube Cells by Natural and Environmental Estrogens‏ ‎‡9  1‏
919 ‎‡a  oviductcellsexpressthecyclicampadenosinepathway‏ ‎‡A  Oviduct cells express the cyclic AMP-adenosine pathway‏ ‎‡9  1‏
919 ‎‡a  oviductcellsexpressthecyclicampadenosinepathway1‏ ‎‡A  Oviduct Cells Express the Cyclic AMP-Adenosine Pathway1‏ ‎‡9  1‏
919 ‎‡a  participationofprostaglandinsinthecontrolofreninrelease‏ ‎‡A  Participation of prostaglandins in the control of renin release‏ ‎‡9  1‏
919 ‎‡a  proteomicanalysisofestrogenmediatedenhancementofmesenchymalstemcellinducedangiogenesisinvivo‏ ‎‡A  Proteomic Analysis of Estrogen-Mediated Enhancement of Mesenchymal Stem Cell-Induced Angiogenesis In Vivo‏ ‎‡9  1‏
919 ‎‡a  purinemetabolitesintumorderivedexosomesmayfacilitateimmuneescapeofheadandnecksquamouscellcarcinoma‏ ‎‡A  Purine Metabolites in Tumor-Derived Exosomes May Facilitate Immune Escape of Head and Neck Squamous Cell Carcinoma‏ ‎‡9  1‏
919 ‎‡a  rack1regulatesangiotensin2inducedcontractionsofshrpreglomerularvascularsmoothmusclecells‏ ‎‡A  RACK1 regulates angiotensin II-induced contractions of SHR preglomerular vascular smooth muscle cells.‏ ‎‡9  1‏
919 ‎‡a  receptordesensitizationandblockadeofthesuppressiveeffectsofprostaglandine2andadenosineonthecytotoxicactivityofhumanmelanomainfiltratingtlymphocytes‏ ‎‡A  Receptor desensitization and blockade of the suppressive effects of prostaglandin E2 and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes‏ ‎‡9  1‏
919 ‎‡a  regulationof35campinpreglomerularsmoothmuscleandendothelialcellsfromgeneticallyhypertensiverats‏ ‎‡A  Regulation of 3′,5′-cAMP in Preglomerular Smooth Muscle and Endothelial Cells From Genetically Hypertensive Rats‏ ‎‡9  1‏
919 ‎‡a  renalextractionofangiotensin2‏ ‎‡A  Renal Extraction of Angiotensin II‏ ‎‡9  1‏
919 ‎‡a  roleofrenalprostaglandinsinsympatheticallymediatedreninrelaseintherat‏ ‎‡A  Role of renal prostaglandins in sympathetically mediated renin relase in the rat.‏ ‎‡9  1‏
919 ‎‡a  roleofrenalprostaglandinsinsympatheticallymediatedreninreleaseintherat‏ ‎‡A  Role of Renal Prostaglandins in Sympathetically Mediated Renin Release in the Rat‏ ‎‡9  1‏
919 ‎‡a  saralasininducedreninreleaseitsblockadebyprostaglandinsynthesisinhibitorsintheconsciousrat‏ ‎‡A  Saralasin-induced renin release: its blockade by prostaglandin synthesis inhibitors in the conscious rat‏ ‎‡9  1‏
919 ‎‡a  suppressionoflymphocytefunctionsbyplasmaexosomescorrelateswithdiseaseactivityinpatientswithheadandneckcancer‏ ‎‡A  Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer‏ ‎‡9  1‏
919 ‎‡a  synergistictherapeuticeffectsof2methoxyestradiolwitheithersildenafilorbosentanonameliorationofmonocrotalineinducedpulmonaryhypertensionandvascularremodeling‏ ‎‡A  Synergistic Therapeutic Effects of 2-Methoxyestradiol With Either Sildenafil or Bosentan on Amelioration of Monocrotaline-induced Pulmonary Hypertension and Vascular Remodeling‏ ‎‡9  1‏
919 ‎‡a  effectsofintravenousinfusionsofselectiveadenosinea1receptoranda2receptoragonistsonmyocardialreperfusioninjury‏ ‎‡A  The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury‏ ‎‡9  1‏
919 ‎‡a  insitubloodperfusedratmesenteryamodelforassessingmodulationofadrenergicneurotranmission‏ ‎‡A  The in situ blood perfused rat mesentery; A model for assessing modulation of adrenergic neurotranmission‏ ‎‡9  1‏
919 ‎‡a  insitubloodperfusedratmesenteryamodelforassessingmodulationofadrenergicneurotransmission‏ ‎‡A  The in situ blood perfused rat mesentery; a model for assessing modulation of adrenergic neurotransmission‏ ‎‡9  1‏
919 ‎‡a  influenceofchemotherapyonadenosineproducingbcellsinpatientswithheadandnecksquamouscellcarcinoma‏ ‎‡A  The influence of chemotherapy on adenosine-producing B cells in patients with head and neck squamous cell carcinoma‏ ‎‡9  1‏
919 ‎‡a  α2adrenoceptorschallengesandopportunitiesenlightenmentfromthekidney‏ ‎‡A  α 2-Adrenoceptors: Challenges and Opportunities-Enlightenment from the Kidney‏ ‎‡9  1‏
919 ‎‡a  effectsofshorttermbetablockadeonbloodpressureplasmathromboxaneb2andplasmaandurinaryprostaglandinse2andf2alphainnormalsubjects‏ ‎‡A  Effects of short-term beta blockade on blood pressure, plasma thromboxane B2, and plasma and urinary prostaglandins E2 and F2 alpha in normal subjects‏ ‎‡9  1‏
996 ‎‡2  ISNI|000000038745295X‏
996 ‎‡2  LC|n 2024058573‏
996 ‎‡2  NUKAT|n 2018286370‏
996 ‎‡2  JPG|500001090‏
996 ‎‡2  BNF|12396133‏
996 ‎‡2  LC|no 92029341‏
996 ‎‡2  ISNI|000000008294331X‏
996 ‎‡2  DNB|1292898739‏
996 ‎‡2  ISNI|0000000108107118‏
996 ‎‡2  ISNI|0000000383719047‏
996 ‎‡2  ISNI|0000000039966380‏
996 ‎‡2  LC|n 85311695‏
996 ‎‡2  RERO|A022864001‏
996 ‎‡2  LC|no2012059238‏
996 ‎‡2  LC|n 2013065176‏
996 ‎‡2  SUDOC|241207150‏
996 ‎‡2  NII|DA09954462‏
996 ‎‡2  LC|n 79065537‏
996 ‎‡2  LC|no2024089689‏
996 ‎‡2  NII|DA0179476X‏
996 ‎‡2  NII|DA15871122‏
996 ‎‡2  PLWABN|9811346338105606‏
996 ‎‡2  J9U|987007457559705171‏
996 ‎‡2  DNB|172165342‏
996 ‎‡2  ISNI|0000000030011764‏
996 ‎‡2  NII|DA03657635‏
996 ‎‡2  JPG|500227816‏
996 ‎‡2  NII|DA15708132‏
996 ‎‡2  ISNI|0000000084286288‏
996 ‎‡2  ISNI|000000050085410X‏
996 ‎‡2  ISNI|0000000050890604‏
996 ‎‡2  RERO|A005840134‏
996 ‎‡2  SUDOC|188346058‏
996 ‎‡2  LC|no 97002081‏
996 ‎‡2  LC|n 96113252‏
996 ‎‡2  J9U|987007345584305171‏
996 ‎‡2  LC|n 2006161931‏
996 ‎‡2  SUDOC|142857564‏
996 ‎‡2  ISNI|0000000110854577‏
996 ‎‡2  LC|n 92101515‏
996 ‎‡2  LC|no 94024941‏
996 ‎‡2  RERO|A011623579‏
996 ‎‡2  DNB|120326213‏
996 ‎‡2  LC|n 91080627‏
996 ‎‡2  SUDOC|080651100‏
996 ‎‡2  ISNI|0000000036235777‏
996 ‎‡2  RERO|A011135546‏
996 ‎‡2  BIBSYS|90245769‏
996 ‎‡2  ISNI|0000000084833202‏
996 ‎‡2  DNB|1211656284‏
996 ‎‡2  DNB|1185841687‏
996 ‎‡2  LC|n 98802268‏
996 ‎‡2  RERO|A016616931‏
996 ‎‡2  LC|nr 96026688‏
996 ‎‡2  RERO|A022773644‏
996 ‎‡2  LC|no 99061597‏
996 ‎‡2  BIBSYS|99030733‏
996 ‎‡2  J9U|987007322547105171‏
996 ‎‡2  RERO|A003415389‏
996 ‎‡2  LC|n 2012051352‏
996 ‎‡2  BIBSYS|3095022‏
996 ‎‡2  NII|DA06355268‏
996 ‎‡2  CAOONL|ncf11194042‏
996 ‎‡2  PTBNP|1328222‏
996 ‎‡2  ISNI|0000000083886652‏
996 ‎‡2  NTA|136932002‏
996 ‎‡2  NTA|202454665‏
996 ‎‡2  LC|no2022063888‏
996 ‎‡2  LC|n 87814335‏
996 ‎‡2  LC|n 83220633‏
996 ‎‡2  BNF|17926617‏
996 ‎‡2  BIBSYS|90622859‏
996 ‎‡2  LC|no2002036803‏
996 ‎‡2  LC|n 2009024490‏
996 ‎‡2  ISNI|0000000080428832‏
996 ‎‡2  NTA|130248371‏
996 ‎‡2  SUDOC|243220952‏
996 ‎‡2  ISNI|0000000034974840‏
996 ‎‡2  ISNI|0000000075142848‏
996 ‎‡2  ISNI|0000000029917761‏
996 ‎‡2  N6I|vtls002782862‏
996 ‎‡2  ISNI|0000000118703722‏
996 ‎‡2  NTA|173794416‏
996 ‎‡2  CAOONL|ncf10430120‏
996 ‎‡2  ISNI|0000000059441952‏
996 ‎‡2  DNB|1089791364‏
996 ‎‡2  LC|no2021089742‏
996 ‎‡2  ISNI|0000000435038623‏
996 ‎‡2  NDL|00514071‏
996 ‎‡2  JPG|500237650‏
996 ‎‡2  CAOONL|ncf10094130‏
996 ‎‡2  ISNI|000000040719096X‏
996 ‎‡2  LC|n 2004034729‏
996 ‎‡2  JPG|500447391‏
996 ‎‡2  J9U|987007324521205171‏
996 ‎‡2  DNB|1225940524‏
996 ‎‡2  LC|n 87814529‏
996 ‎‡2  J9U|987007330184405171‏
996 ‎‡2  LC|n 89608892‏
996 ‎‡2  LC|nb 99105893‏
996 ‎‡2  ISNI|0000000031603155‏
996 ‎‡2  LC|n 98059921‏
996 ‎‡2  BNE|XX1687646‏
996 ‎‡2  BIBSYS|98026325‏
996 ‎‡2  LC|n 85060620‏
996 ‎‡2  LC|no2011039503‏
996 ‎‡2  SUDOC|166311316‏
996 ‎‡2  NTA|108042847‏
996 ‎‡2  LC|n 92014954‏
996 ‎‡2  LC|nr 92028129‏
996 ‎‡2  ISNI|0000000059096167‏
996 ‎‡2  SUDOC|076188256‏
996 ‎‡2  LC|n 88677588‏
996 ‎‡2  NLA|000035239319‏
996 ‎‡2  LC|n 2005074239‏
996 ‎‡2  ISNI|0000000024321272‏
996 ‎‡2  NUKAT|n 02091557‏
996 ‎‡2  LC|nb2012007180‏
996 ‎‡2  SUDOC|110357019‏
996 ‎‡2  NTA|241632943‏
996 ‎‡2  LC|n 2022044237‏
996 ‎‡2  SELIBR|216331‏
996 ‎‡2  LC|no2020129961‏
996 ‎‡2  DNB|1055525459‏
996 ‎‡2  ISNI|0000000078968274‏
996 ‎‡2  LC|n 88073829‏
996 ‎‡2  ISNI|0000000027557889‏
996 ‎‡2  BNF|13522904‏
996 ‎‡2  CAOONL|ncf11191241‏
996 ‎‡2  RERO|A003415385‏
996 ‎‡2  LC|n 2017059506‏
996 ‎‡2  J9U|987007443579605171‏
996 ‎‡2  LC|no 00025215‏
996 ‎‡2  NTA|07209382X‏
996 ‎‡2  LC|no2018017499‏
996 ‎‡2  NKC|xx0047285‏
996 ‎‡2  SUDOC|240556275‏
996 ‎‡2  N6I|vtls001336966‏
996 ‎‡2  LC|n 87012325‏
996 ‎‡2  J9U|987009157186605171‏
996 ‎‡2  LC|nr2001045574‏
996 ‎‡2  ISNI|0000000082054563‏
996 ‎‡2  LC|no2020103336‏
996 ‎‡2  ISNI|0000000041973408‏
996 ‎‡2  LC|n 83222379‏
996 ‎‡2  CAOONL|ncf10094458‏
996 ‎‡2  ISNI|0000000107989083‏
996 ‎‡2  LC|n 82108425‏
996 ‎‡2  LC|n 50035224‏
996 ‎‡2  CAOONL|ncf10002279‏
996 ‎‡2  LC|n 84161325‏
996 ‎‡2  JPG|500227928‏
996 ‎‡2  ISNI|0000000027223088‏
996 ‎‡2  SUDOC|266225438‏
996 ‎‡2  J9U|987007295047805171‏
996 ‎‡2  J9U|987007396770405171‏
996 ‎‡2  LNB|LNC10-000006062‏
996 ‎‡2  ISNI|0000000041454712‏
996 ‎‡2  BNF|12279807‏
996 ‎‡2  ISNI|0000000367876691‏
996 ‎‡2  NUKAT|n 2002066648‏
996 ‎‡2  J9U|987007338235105171‏
996 ‎‡2  LC|n 2020025246‏
996 ‎‡2  DBC|87097919015815‏
996 ‎‡2  LC|no2022049018‏
996 ‎‡2  ISNI|0000000378123070‏
996 ‎‡2  SUDOC|230631886‏
996 ‎‡2  J9U|987007374097205171‏
996 ‎‡2  LC|no2018155785‏
996 ‎‡2  LC|n 96044678‏
996 ‎‡2  ISNI|0000000026396083‏
996 ‎‡2  LC|nb2011028683‏
996 ‎‡2  NTA|192812424‏
996 ‎‡2  ISNI|0000000034594135‏
996 ‎‡2  CAOONL|ncf11782498‏
996 ‎‡2  LC|no2019163598‏
996 ‎‡2  LC|no2010100155‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏